Get started
Author

Mariana Fe García-Sepulcre

Observed names: M F Garcia-Sepulcre, M F García-Sepulcre, M Fe García-Sepulcre, M García-Sepulcre, M. F. García-Sepulcre, M. García-Sepulcre, M.F. García Sepulcre, M.F. García‐Sepulcre, Mari Fe Garcia‐Sepulcre, Mariana F García-Sepulcre, Mariana F. García-Sepulcre, Mariana Fe García Sepulcre, Mariana Fe García‐Sepulcre, Mariana Fe garcía-sepulcre, Mariana García-Sepulcre
ORCID: 0000-0002-1329-9529
Observed ORCID: 0000-0002-1329-9529
OpenAlex ID: A5031672687
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
2016 · M J Casanova, M Chaparro, et al. · The American Journal of Gastroenterology · 114
PDF
Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
2018 · María Chaparro, Ana Garre, et al. · Alimentary Pharmacology & Therapeutics · 107
PDF
Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era
2013 · T. Nunes, M. J. Etchevers, et al. · Alimentary Pharmacology & Therapeutics · 93
PDF
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry
2019 · M. Iborra, B. Beltrán, et al. · Alimentary Pharmacology & Therapeutics · 74
Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study
2017 · I Ordás, E Domènech, et al. · The American Journal of Gastroenterology · 66
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry
2020 · Alicia Algaba, Iván Guerra, et al. · Digestive Diseases and Sciences · 57
Factors associated with non-attendance at outpatient endoscopy
2008 · Javier Sola-vera, Jesús Sáez, et al. · Scandinavian Journal of Gastroenterology · 56
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry
2019 · María José Casanova, María Chaparro, et al. · Inflammatory Bowel Diseases · 54
PDF
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
2019 · Ivan Guerra, Luis Bujanda, et al. · Journal of Crohn s and Colitis · 54
Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy
2010 · José M. Ramos, Mariana F. García-Sepulcre, et al. · Journal of Medical Microbiology · 38
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry
2017 · María Chaparro, M Ramas, et al. · The American Journal of Gastroenterology · 33
Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases
2012 · José M. Ramos, Mar Masiá, et al. · Clinical and Experimental Medicine · 28
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
2022 · Manuel Barreiro-de Acosta, Agnès Fernández-Clotet, et al. · The American Journal of Gastroenterology · 24
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
2019 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Therapeutic Advances in Gastroenterology · 24
The Colonoscopy Satisfaction and Safety Questionnaire (CSSQP) for Colorectal Cancer Screening: A Development and Validation Study
2019 · Alicia Brotons, Mercedes Guilabert, et al. · International Journal of Environmental Research and Public Health · 23
PDF
The experience of inflammatory bowel disease patients with healthcare: A survey with the IEXPAC instrument
2019 · Ignacio Marín-Jiménez, Francesc Casellas, et al. · Medicine · 22
Cuff-assisted versus cap-assisted colonoscopy for adenoma detection: results of a randomized study
2019 · Javier Sola-Vera, Lourdes Catalá, et al. · Endoscopy · 21
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
2024 · María José Casanova, Berta Caballol, et al. · Digestive and Liver Disease · 19
Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy
2010 · J. M. Ramos, M. F. García-Sepulcre, et al. · Revista Española de Enfermedades Digestivas · 18
PDF
Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis.
2011 · M Martínez-Gabarrón, R Enríquez, et al. · PubMed · 16
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry
2021 · Margalida Calafat, Míriam Mañosa, et al. · Journal of Crohn s and Colitis · 14
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
2022 · Yamile Zabana, Ignacio Marín-Jiménez, et al. · Journal of Clinical Medicine · 13
Successful Treatment of Severe Gastrointestinal Bleeding Secondary to Crohn Disease with Recombinant Factor VIIa
2007 · Eva Girona, Joaquín Borrás-Blasco, et al. · Southern Medical Journal · 12
Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease [Correspondence]
2014 · Mar Masiá, Maravillas Martínez, et al. · The International Journal of Tuberculosis and Lung Disease · 9
Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW ‐ IBD Study of ENEIDA
2025 · Cristina Rubín de Célix, Elena Ricart, et al. · Alimentary Pharmacology & Therapeutics · 8
Works count: 57
Citation count: 1,056
H-index: 18
I10-index: 24
Year
Topic
Type